8 completed, 2 withdrawn. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 8, Withdrawn 2 |
Follow High Blood Pressure: new trials by email Literature Review of High Blood Pressure trials Research Report on High Blood Pressure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN) Amlodipine Besylate, Chlorthalidone - High Blood Pressure, Liver Transplant | Phase 4 | Withdrawn | Northwestern University | 2022-07-12 | 2023-10-13 | |
| Treating Nocturnal Hypertension and Nocturia in African American Men Thiazide Treatment Group, Intensified Thiazide Treatment Group, Combination Medication Treatment Group - High Blood Pressure | Phase 4 | Withdrawn | Cedars-Sinai Medical Center | 2017-10-25 | 2021-02-04 | |
| Intensive Vasodilator Therapy in Patients With Essential Hypertension Amlodipine, Ramipril, Lercanidipine - Essential Hypertension, High Blood Pressure | Phase 4 | Completed | Aarhus University Hospital | 48 | 2010-12-01 | 2012-04-19 |
| A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients. Aliskiren and HCTZ - High Blood Pressure | Phase 4 | Completed | Novartis | 253 | 2010-02-01 | 2017-02-23 |
| The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension Nebivolol, Metoprolol XL - High Blood Pressure | Phase 4 | Completed | Emory University | 91 | 2009-12-01 | 2017-04-11 |
| The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function Aliskiren 150 mg, Placebo, HCTZ - High Blood Pressure | Phase 4 | Completed | Vanderbilt University Medical Center | 31 | 2009-06-01 | 2017-08-25 |
| To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone Amlodipine 5mg/Valsartan 80 mg, Valsartan - Hypertension, High Blood Pressure | Phase 4 | Completed | Novartis | 60 | 2009-06-01 | 2011-10-19 |
| Magnesium and Metabolic Syndrome Magnesium chloride, Placebo - Diabetes Mellitus, High Blood Pressure | Phase 4 | Completed | Instituto Mexicano del Seguro Social | 85 | 2006-07-01 | 2008-01-29 |
| Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension Bunazosin, Doxazosin, Valsartin - High Blood Pressure | Phase 4 | Completed | Eisai Inc. | 93 | 2005-10-01 | 2013-05-14 |
| ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED) losartan potassium, Comparator: Placebo - High Blood Pressure | Phase 4 | Completed | Organon and Co | 367 | 2000-03-14 | 2024-08-15 |
Hypertension (10) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Essential Hypertension (1) · Vascular Diseases (1)
Cardiovascular Diseases (9) · Vascular Diseases (9) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Amlodipine (3) · Hydrochlorothiazide (2) · Losartan (2) · Valsartan (2) · aliskiren (2) · Amlodipine, Valsartan Drug Combination (1) · Chlorthalidone (1) · Doxazosin (1) · Magnesium Chloride (1) · Metoprolol (1) · Nebivolol (1) · Ramipril (1) · bunazosin (1) · lercanidipine (1)
Novartis (2) · Aarhus University Hospital (1) · Cedars-Sinai Medical Center (1) · Eisai Inc. (1) · Emory University (1) · Instituto Mexicano del Seguro Social (1) · Northwestern University (1) · Organon and Co (1) · Vanderbilt University Medical Center (1)
United States (4) · Taiwan (2) · Denmark (1) · Mexico (1) · Venezuela (1)
Ashkan Eftekhari, MD, PhD (1) · Dempsey Hughes, MD (1) · Martha Rodriguez-Moran, MD, MSc, PhD (1) · Morten Engholm Pedersen, MD (1) · Niels Henrik Buus, DMSc (1) · Ole Norling Mathiasen, MD, PhD (1) · Ya-hui Cheng (1)
R56HL155093 (1)